Condition: Lumbar Radiculopathy · Radicular Low Back Pain · Sponsor: Universitaire Ziekenhuizen KU Leuven
The R³ trial is a multicentre cluster randomized controlled trial evaluating an evidence-based, person-centred rehabilitation pathway for patients undergoing lumbar surgery for radicular pain. The pathway includes structured pre-, peri-, and postoperative rehabilitation, early postoperative mobilization, case management, early return-to-work (RTW) guidance, and patient empowerment. Clusters (hospitals) are randomized to implement the R³ pathway (intervention) or continue usual care (control). The primary aim is to determine whether the R³ pathway reduces time to return to work compared with usual care.
This description comes directly from the study's public registry record.
Olivier Nachtergaele, MD · +32 16 34 02 72 · olivier.nachtergaele@uzleuven.be
Always discuss trial participation with your own doctor first.
| ZAS | Antwerp, Belgium | Not Yet Recruiting |
| AZ Sint Jan Brugge | Bruges, Belgium | Recruiting |
| UZ Brussel | Brussels, Belgium | Not Yet Recruiting |
| Grand Hôpital de Charleroi | Charleroi, Belgium | Not Yet Recruiting |
| Ziekenhuis Geel | Geel, Belgium | Not Yet Recruiting |
| ZOL Genk | Genk, Belgium | Recruiting |
| Jessa Ziekenhuis | Hasselt, Belgium | Not Yet Recruiting |
| AZ Herentals | Herentals, Belgium | Not Yet Recruiting |
| Jan Yperman ziekenhuis | Ieper, Belgium | Not Yet Recruiting |
| AZ Groeninge Kortrijk | Kortrijk, Belgium | Not Yet Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| Heilig Hart Lier | Lier, Belgium | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07313566